UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacological characterization of the selective orexin-1 receptor antagonist JNJ-61393215 in healthy volunteers

Journal of psychopharmacology (Oxford), 2023-06, Vol.37 (6), p.577-589

2023

Volltextzugriff (PDF)

A placebo‐controlled trial of the 5‐HT1A agonist R‐137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia

Neurogastroenterology and motility, 2009-06, Vol.21 (6), p.619-e24

2009

Volltextzugriff (PDF)

Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism

The Journal of pharmacology and experimental therapeutics, 1995-09, Vol.274 (3), p.1067

1995

Volltextzugriff (PDF)

The influence of the novel 5‐HT1A agonist R137696 on the proximal stomach function in healthy volunteers

Neurogastroenterology and motility, 2006-10, Vol.18 (10), p.919-926

2006

Volltextzugriff (PDF)

Progression of prodromal motor and non‐motor symptoms in the premotor phase study – 2‐year follow‐up data

European journal of neurology, 2017-11, Vol.24 (11), p.1369-1374

2017

Volltextzugriff (PDF)

Translational neurophysiological markers for activity of the metabotropic glutamate receptor (mGluR2) modulator JNJ-40411813: Sleep EEG correlates in rodents and healthy men

Neuropharmacology, 2016-04, Vol.103, p.290-305

2016

Volltextzugriff (PDF)

Nebivolol vs atenolol and placebo in essential hypertension : a double-blind randomised trial

Journal of human hypertension, 1998-02, Vol.12 (2), p.135-140

1998

Volltextzugriff (PDF)

Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes

Journal of human hypertension, 1997-11, Vol.11 (11), p.753-757

1997

Volltextzugriff (PDF)

P.2.f.005 Efficacy and safety of a novel mGlu2 receptor positive allosteric modulator as an adjunctive treatment in anxious depression

European neuropsychopharmacology, 2014-10, Vol.24, p.S453-S454

2014

Volltextzugriff (PDF)

P.2.b.017 Onset of efficacy of ketamine in treatment-resistant depression: a double-blind, randomised, placebo-controlled, dose frequency study

European neuropsychopharmacology, 2014-10, Vol.24, p.S387-S388

2014

Volltextzugriff (PDF)

Pharmacological properties of nebivolol in man

European journal of clinical pharmacology, 1997, Vol.51 (5), p.379-384

1997

Volltextzugriff (PDF)

The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia

Journal of psychopharmacology (Oxford), 2019-02, Vol.33 (2), p.202-209

2019

Volltextzugriff (PDF)

Nebivolol vs enalapril in the treatment of essential hypertension : a double-blind randomised trial

Journal of human hypertension, 1997-12, Vol.11 (12), p.813-819

1997

Volltextzugriff (PDF)

P.3.a.026 Safety, tolerability and D2 occupancy of the fast dissociating D2 antagonist JNJ-37822681 in healthy subjects

European neuropsychopharmacology, 2010, Vol.20, p.S444-S444

2010

Volltextzugriff (PDF)

A dose-response trial of nebivolol in essential hypertension

Journal of human hypertension, 1997-02, Vol.11 (2), p.139-144

1997

Volltextzugriff (PDF)

Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease

Neurobiology of aging, 2019-07, Vol.79, p.131-141

2019

Volltextzugriff (PDF)

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study

Alzheimer's research & therapy, 2018-08, Vol.10 (1), p.85-85, Article 85

2018

Volltextzugriff (PDF)

P.3.c.039 Sustained treatment response in schizophrenia to JNJ-37822681 can be predicted within three days

European neuropsychopharmacology, 2011, Vol.21, p.S490-S491

2011

Volltextzugriff (PDF)

Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects

Journal of psychopharmacology (Oxford), 2018-12, Vol.32 (12), p.1330-1340

2018

Volltextzugriff (PDF)

Evaluating Potential QT Effects of JNJ‐54861911, a BACE Inhibitor in Single‐ and Multiple‐Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration‐QTc Analysis

Journal of clinical pharmacology, 2018-07, Vol.58 (7), p.952-964

2018

Volltextzugriff (PDF)

Efficacy and safety of oral ridogrel in the treatment of ulcerative colitis: two multicentre, randomized, double‐blind studies

Alimentary pharmacology & therapeutics, 2002-01, Vol.16 (1), p.87-99

2002

Volltextzugriff (PDF)

Nebivolol Versus Enalapril In Essential Hypertension: A Long-Term Double-Blind Comparative Trial

Acta clinica belgica (English ed. Online), 1999-01, Vol.54 (1), p.19-25

1999

Volltextzugriff (PDF)

Nebivolol : Comparison of the effects of dl-nebivolol, d-nebivolol, l-nebivolol, atenolol, and placebo on exercise-induced increases in heart rate and systolic blood pressure

Cardiovascular drugs and therapy, 1998-09, Vol.12 (4), p.339-344

1998

Volltextzugriff (PDF)

Nebivolol versus nifedipine in the treatment of essential hypertension: a double-blind, randomized, comparative trial

American journal of therapeutics, 1998-07, Vol.5 (4), p.237-244

1998

Volltextzugriff (PDF)

Nebivolol in the treatment of cardiac failure: A double-blind controlled clinical trial

Journal of cardiac failure, 1997-12, Vol.3 (4), p.271-276

1997

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(72)
Tagungsberichte
(1)

Sprache

Englisch
(72)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(37)
Humans
(29)
Male
(27)
Adult
(22)
Middle Aged
(20)
Female
(19)
Biological And Medical Sciences
(18)
Animals
(17)
Medical Sciences
(16)
Pharmacology & Pharmacy
(16)
Nebivolol
(15)
Pharmacology. Drug Treatments
(15)
Aged
(14)
Double-Blind Method
(14)
Neurosciences
(12)
Cardiovascular System
(11)
Neurosciences & Neurology
(11)
Adrenergic Beta-Antagonists - Therapeutic Use
(9)
Antihypertensive Agents
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacological characterization of the selective orexin-1 receptor antagonist JNJ-61393215 in healthy volunteers

A placebo‐controlled trial of the 5‐HT1A agonist R‐137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia

Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism

The influence of the novel 5‐HT1A agonist R137696 on the proximal stomach function in healthy volunteers

Progression of prodromal motor and non‐motor symptoms in the premotor phase study – 2‐year follow‐up data

Translational neurophysiological markers for activity of the metabotropic glutamate receptor (mGluR2) modulator JNJ-40411813: Sleep EEG correlates in rodents and healthy men

Nebivolol vs atenolol and placebo in essential hypertension : a double-blind randomised trial

Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes

P.2.f.005 Efficacy and safety of a novel mGlu2 receptor positive allosteric modulator as an adjunctive treatment in anxious depression

P.2.b.017 Onset of efficacy of ketamine in treatment-resistant depression: a double-blind, randomised, placebo-controlled, dose frequency study

Pharmacological properties of nebivolol in man

The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia

Nebivolol vs enalapril in the treatment of essential hypertension : a double-blind randomised trial

P.3.a.026 Safety, tolerability and D2 occupancy of the fast dissociating D2 antagonist JNJ-37822681 in healthy subjects

A dose-response trial of nebivolol in essential hypertension

Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study

P.3.c.039 Sustained treatment response in schizophrenia to JNJ-37822681 can be predicted within three days

Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects

Evaluating Potential QT Effects of JNJ‐54861911, a BACE Inhibitor in Single‐ and Multiple‐Ascending Dose Studies, and a Thorough QT Trial With Additional Retrospective Confirmation, Using Concentration‐QTc Analysis

Efficacy and safety of oral ridogrel in the treatment of ulcerative colitis: two multicentre, randomized, double‐blind studies

Nebivolol Versus Enalapril In Essential Hypertension: A Long-Term Double-Blind Comparative Trial

Nebivolol : Comparison of the effects of dl-nebivolol, d-nebivolol, l-nebivolol, atenolol, and placebo on exercise-induced increases in heart rate and systolic blood pressure

Nebivolol versus nifedipine in the treatment of essential hypertension: a double-blind, randomized, comparative trial

Nebivolol in the treatment of cardiac failure: A double-blind controlled clinical trial

Suchergebnisse filtern